Erythropoietin-alfa during neoadjuvant chemotherapy for locally advanced esophagogastric adenocarcinoma.

Abbrederis, Kathrin

Erythropoietin-alfa during neoadjuvant chemotherapy for locally advanced esophagogastric adenocarcinoma. [electronic resource] - The Annals of thoracic surgery Jul 2006 - 293-7 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

1552-6259

10.1016/j.athoracsur.2006.01.097 doi


Adenocarcinoma--drug therapy
Aged
Anastomosis, Surgical
Anemia--chemically induced
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Blood Transfusion--statistics & numerical data
Cisplatin--administration & dosage
Combined Modality Therapy
Epoetin Alfa
Erythropoietin--therapeutic use
Esophageal Neoplasms--drug therapy
Esophagectomy
Esophagogastric Junction
Female
Fluorouracil--administration & dosage
Gastrectomy
Hemoglobins--analysis
Humans
Leucovorin--administration & dosage
Male
Middle Aged
Neoadjuvant Therapy
Organoplatinum Compounds--administration & dosage
Oxaliplatin
Paclitaxel--administration & dosage
Postoperative Complications--epidemiology
Prospective Studies
Recombinant Proteins
Stomach Neoplasms--drug therapy
Survival Analysis